Denosumab is a human IgG2 monoclonal antibody with affinity and specificity for human receptor activator of nuclear factor kappa-B ligand. The trade name of this medicine is Prolia. The active ingredient is Denosumab, and inactive ingredients are sorbitol, acetate, polysorbate 20 and water. It comes in the form of a solution for subcutaneous injection in standard strength of 60 mg.
The general dosage of Denosumab 60 mg injection is to administer 60 mg every 6 months in the upper arm, upper thigh, or abdomen as per the professional's guidelines. The common side-effects of the medicine are as follows: Anemia, Angina pectoris, Atrial fibrillation, Vertigo, Abdominal pain upper, Flatulence, Gastroesophageal reflux disease, Edema peripheral, Asthenia, Cystitis, Upper respiratory tract infection, Pneumonia, Pharyngitis, Herpes zoster, Hypercholesterolemia, Back pain, Musculoskeletal pain, Bone pain, Myalgia, Spinal osteoarthritis, Insomnia, Rash, Pruritus, etc.
Not every patient experiences these side effects, but if one does, consult the physician immediately. And in case of overdose, the health professional will continuously monitor the patient for worsening signs and symptoms.
The Denosumab cost offered by innovators is much costly as compared to the price available in India. There are numerous trusted suppliers in India, and Ikris Pharma is one of them. Ikris is a certified supplier of such medicines in India and overseas.
